Inhibiting HDAC6 Enzyme Has Potential for Treating FRX, Mouse Study Finds
News
Inhibiting the HDAC6 enzyme with an experimental agent called SW-100 improved memory and lowered learning impairments in a mouse model of fragile X syndrome (FXS), a study has shown. ... Read more